Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Video
All Video TypesAJMC TVGuidelinesInsightsOnLocationPayer PerspectivesPeer ExchangePost Conference PerspectivesShortsStakeholder Summit
Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
More
Conferences
Conference CoverageConference ListingPost Conference Perspectives
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Video
  • Podcasts
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement
|Videos|February 9, 2022

Potential Changes for MRD in the Future

Kashyap Patel, MD, and Jason Starr, DO, explain the potential changes providers might see in the future for MRD.

Advertisement

Episodes in this series

EP. 1 Explaining Molecular Residual Disease
EP. 1 Explaining Molecular Residual Disease
EP. 2 The Evolution of Circulating Tumor DNA in Oncology
EP. 2 The Evolution of Circulating Tumor DNA in Oncology
EP. 3 MRD Assessments
EP. 3 MRD Assessments
EP. 4 MRD Results and Guiding Treatment Decisions
EP. 4 MRD Results and Guiding Treatment Decisions
EP. 5 MRD and Value-Based Care Models
EP. 5 MRD and Value-Based Care Models
EP. 6 Supporting MRD Availability
EP. 6 Supporting MRD Availability
EP. 7 INSPIRE and IMvigor011 Trials
EP. 7 INSPIRE and IMvigor011 Trials
EP. 8 Potential Changes for MRD in the Future
Now Playing
EP. 8 Potential Changes for MRD in the Future
Advertisement
News Network
|
Video Series
|
Clinical
|
Guiding Appropriate Cancer Treatment with Molecular Residual Disease Testing

Related Content

Advertisement
Tarik Asselah, MD, PhD, screenshot on AJMC branded Q&A background

HDV Combo Shows No Relapses at 2 Years: Tarik Asselah, MD, PhD

ByLaura Joszt, MA,Tarik Asselah, MD, PhD
June 16th 2026
ChronicLL | Image Credit: © Saiful52-stock.adobe.com

Venetoclax-Obinutuzumab Tops Acalabrutinib in First-Line CLL

ByMaggie L. Shaw
June 16th 2026
United Therapeutics plans to seek FDA approval for inhaled treprostinil after phase 3 TETON trials demonstrated improved preservation of lung function in IPF. | Image credit: Peakstock_AdobeStock.jpeg

United Therapeutics Plans FDA Submission for Inhaled Treprostinil in IPF

BySabrina McCrear
June 16th 2026
Dr Fabio Efficace | Image Credit: GIMEMA Foundation

Patient-Reported QOL Provides Prognostic Insight in AML: Fabio Efficace, PhD, MSc

ByBrooke McCormick,Fabio Efficace, PhD, MSc
June 16th 2026

Investing in the Future: Redesigning Healthcare Infrastructure for CRM Excellence

ByIan J. Neeland, MD
June 16th 2026
Advertisement
Advertisement

Trending on AJMC

1

Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies

2

AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike

3

ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity

4

CMS Proposes Permanent Rules for Medicare Drug Price Negotiation

5

United Therapeutics Plans FDA Submission for Inhaled Treprostinil in IPF

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text